vidarabine has been researched along with Osteomyelitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holmes, NE; Kelman, A; Korman, TM; Opat, S | 1 |
| Ajana, F; Ettahar, N; Legout, L; Massongo, M; Patoz, P; Rose, C; Senneville, E | 1 |
| Gadea, I; Llamas, P; Prieto, E; Román, A; Santos, AB; Subirá, D; Tomás, JF | 1 |
1 review(s) available for vidarabine and Osteomyelitis
| Article | Year |
|---|---|
[Cryptococcal osteomyelitis in a patient with a lymphocytic leukemia treated with fludarabine-cyclophosphamide-rituximab].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcosis; Cryptococcus neoformans; Cutaneous Fistula; Cyclophosphamide; Diabetes Mellitus, Type 2; Female; Fungemia; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Diseases, Fungal; Neutropenia; Opportunistic Infections; Osteolysis; Osteomyelitis; Rituximab; Vidarabine | 2013 |
2 other study(ies) available for vidarabine and Osteomyelitis
| Article | Year |
|---|---|
Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemia.
Topics: Aged; Angiomatosis, Bacillary; Anti-Bacterial Agents; Antineoplastic Agents; Bacteriological Techniques; Bartonella quintana; Drug Therapy; Female; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphatic Diseases; Microscopy; Osteomyelitis; Treatment Failure; Vidarabine | 2011 |
Aspergillus fumigatus: a rare cause of vertebral osteomyelitis.
Topics: Aspergillus fumigatus; Humans; Leukemia, B-Cell; Opportunistic Infections; Osteomyelitis; Purine Nucleosides; Spinal Diseases; Vidarabine | 2004 |